Fosfomycin Not Noninferior to Comparators for Bacteremic UTI

FRIDAY, Jan. 14, 2022 -- For patients with bacteremic urinary tract infections (bUTIs) due to multidrug-resistant (MDR) Escherichia coli, fosfomycin is not noninferior to comparators, with an increased rate of adverse event-related discontinuations,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news